Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke

BACKGROUND: Stroke is a leading cause of death and disability, and despite intensive research, few treatment options exist. However, a recent breakthrough in cell therapy is expected to reverse the neurological sequelae of stroke. Although some pioneer studies on the use of cell therapy for treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Shichinohe, Hideo, Kawabori, Masahito, Iijima, Hiroaki, Teramoto, Tuyoshi, Abumiya, Takeo, Nakayama, Naoki, Kazumata, Ken, Terasaka, Shunsuke, Arato, Teruyo, Houkin, Kiyohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591569/
https://www.ncbi.nlm.nih.gov/pubmed/28886699
http://dx.doi.org/10.1186/s12883-017-0955-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591569/
https://www.ncbi.nlm.nih.gov/pubmed/28886699
http://dx.doi.org/10.1186/s12883-017-0955-6

Ejemplares similares